Should You Hold Akerna Corp (KERN) in Drug Manufacturers

Should You Hold Akerna Corp (KERN) in Drug Manufacturers - Specialty & Generic Industry?

Thursday, November 16, 2023 12:30 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Hold Akerna Corp (KERN) in Drug Manufacturers - Specialty & Generic Industry?

A rating of 74 puts Akerna Corp (KERN) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Akerna Corp's score of 74 means it scores higher than 74% of stocks in the industry. Akerna Corp also received an overall rating of 50, putting it above 50% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 115 out of the 148 industries.

KERN has an Overall Score of 50. Find out what this means to you and get the rest of the rankings on KERN!

See Full KERN Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 50 means the stock is more attractive than 50 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Akerna Corp Stock Today?

Akerna Corp (KERN) stock is unmoved -0.78% while the S&P 500 has fallen -0.07% as of 12:14 PM on Thursday, Nov 16. KERN is unchanged $0.00 from the previous closing price of $0.24 on volume of 63,075 shares. Over the past year the S&P 500 has gained 13.67% while KERN has fallen -79.31%. KERN earned $2.25 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 0.11. Click Here to get the full Stock Report for Akerna Corp stock.